We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cryoablation Found Effective for Atrial Flutter

By HospiMedica staff writers
Posted on 26 Nov 2003
Studies conducted by Italian researchers have shown a success rate of 90-100% when treating typical atrial flutter with cryoablation. More...
The abstracts were presented at the annual International Workshop on Arrhythmias in Venice (Italy).

Of 143 patients, 130 had atrial flutter, of whom 103 were treated with the Freezor Xtra and 27 with the Freezor Max ablation catheters of CryoCath Technologies, Inc. (Montreal, Canada). The results showed the Xtra had an acute success rate of 90%, on a par with radiofrequency (RF) ablation results. The study center was able to improve the success rate to 100% with Max. CryoCath states that by providing the optimal amount of refrigerant over a larger tip, Freezor Max allows doctors to make larger, deeper lesions. It is better suited to treat arrhythmias such as atrial flutter and prevalent left-sided arrhythmias, the company notes, where a more powerful lesion-making catheter is required for anatomical reasons.

"Our center has now performed a total of 31 flutter ablation cases using Freezor Max with a 100% acute success rate,” said Dr. A.S. Montenero of the Policlinico MultiMedica (Milan, Italy). "Our overall success rate with cryoablation is similar to RF ablation, but with the advent of Freezor Max, it's now trending much higher.”




Related Links:
Cryocath

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.